These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33205067)

  • 1. Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation.
    Smith DK; Kates L; Durinck S; Patel N; Stawiski EW; Kljavin N; Foreman O; Sipos B; Solloway MJ; Allan BB; Peterson AS
    Cell Rep Med; 2020 Aug; 1(5):100058. PubMed ID: 33205067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
    Kedees MH; Grigoryan M; Guz Y; Teitelman G
    Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice.
    Yu R; Dhall D; Nissen NN; Zhou C; Ren SG
    PLoS One; 2011; 6(8):e23397. PubMed ID: 21853126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.
    Kim J; Okamoto H; Huang Z; Anguiano G; Chen S; Liu Q; Cavino K; Xin Y; Na E; Hamid R; Lee J; Zambrowicz B; Unger R; Murphy AJ; Xu Y; Yancopoulos GD; Li WH; Gromada J
    Cell Metab; 2017 Jun; 25(6):1348-1361.e8. PubMed ID: 28591637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones.
    Rudenko O; Shang J; Munk A; Ekberg JP; Petersen N; Engelstoft MS; Egerod KL; Hjorth SA; Wu M; Feng Y; Zhou YP; Mokrosinski J; Thams P; Reimann F; Gribble F; Rehfeld JF; Holst JJ; Treebak JT; Howard AD; Schwartz TW
    Mol Metab; 2019 Jan; 19():49-64. PubMed ID: 30472415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
    Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
    Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
    Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
    Zhou C; Dhall D; Nissen NN; Chen CR; Yu R
    Pancreas; 2009 Nov; 38(8):941-6. PubMed ID: 19657311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia.
    Rivero-Gutierrez B; Haller A; Holland J; Yates E; Khrisna R; Habegger K; Dimarchi R; D'Alessio D; Perez-Tilve D
    Mol Metab; 2018 Nov; 17():28-38. PubMed ID: 30170980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.
    Galsgaard KD; Winther-Sørensen M; Ørskov C; Kissow H; Poulsen SS; Vilstrup H; Prehn C; Adamski J; Jepsen SL; Hartmann B; Hunt J; Charron MJ; Pedersen J; Wewer Albrechtsen NJ; Holst JJ
    Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E93-E103. PubMed ID: 28978545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.
    Lee Y; Berglund ED; Yu X; Wang MY; Evans MR; Scherer PE; Holland WL; Charron MJ; Roth MG; Unger RH
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13217-22. PubMed ID: 25157166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis.
    Liu Q; Lin G; Chen Y; Feng W; Xu Y; Lyu J; Yang D; Wang MW
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
    Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
    J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal glucagon signaling and β-cell function after near-total α-cell ablation in adult mice.
    Thorel F; Damond N; Chera S; Wiederkehr A; Thorens B; Meda P; Wollheim CB; Herrera PL
    Diabetes; 2011 Nov; 60(11):2872-82. PubMed ID: 21926270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
    Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
    Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia.
    Castellani LN; Peppler WT; Sutton CD; Whitfield J; Charron MJ; Wright DC
    Psychoneuroendocrinology; 2017 Aug; 82():38-45. PubMed ID: 28500893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease.
    Sipos B; Klöppel G
    Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37260318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.